Urology News and Research

Latest Urology News and Research

Federal suit alleges ‘staggering’ urine drug testing fraud at Tennessee pain clinics

The Justice Department on Monday accused a defunct chain of Tennessee-based pain clinics of cheating Medicare and other taxpayer-funded health insurers out of at least $25 million in needless urine drug tests and genetic testing.

23 Jul 2019

Non-invasive diagnostic method could aid in early detection, monitoring of bladder cancer

This non-invasive diagnostic method could help detect the disease in its earliest stages with a small urine sample.

19 Jul 2019

NHS England pilot paves way for new smartphone-based UTI test

WOMEN who suspect they have a urinary tract infection will be able to access fast-track testing and treatment — without seeing a GP — as part of a ground-breaking NHS England pilot scheme being trialed in 38 ‘Pharmacy First’ branches across Nottinghamshire and Derbyshire.

19 Jul 2019

Study uncovers gene that hides tumor cells from immunotherapy

A team at Fred Hutchinson Cancer Research Center has identified a gene that could make immunotherapy treatments, specifically checkpoint inhibitors, work for a wider variety of cancer patients.

19 Jul 2019

Common medications can masquerade as dementia in seniors

By all accounts the woman, in her late 60s, appeared to have severe dementia. She was largely incoherent. Her short-term memory was terrible. She couldn't focus on questions that medical professionals asked her.

18 Jul 2019

Mathematical model helps quantify metastatic cell behavior

Cancer metastasis is a difficult stage to battle, especially if cancer cells are proliferating at a rapid pace. A new study reveals that metastatic cells change their shape to spread to other parts of the body. Researchers formulated a mathematical model to study metastatic cell behavior and similar cellular systems.

17 Jul 2019

AI-enabled device detects if targeted chemotherapy is working

A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.

17 Jul 2019

UMass Amherst scientist receives $792,000 grant to advance cancer immunotherapy research

Biomedical engineer Ashish Kulkarni, assistant professor of chemical engineering at the University of Massachusetts Amherst, has been awarded a four-year, $792,000 grant from the American Cancer Society to advance his interdisciplinary lab's promising cancer immunotherapy research.

16 Jul 2019

Transobturator sling surgery shows promise for stress urinary incontinence

A recent study from the Mayo Clinic researchers has shown that surgery for management of stress urinary incontinence can yield better results than conservative methods such as exercise and urethral inserts.

16 Jul 2019

Study reveals long-term benefits of stress urinary incontinence surgery

One of the most commonly performed surgeries to treat stress urinary incontinence in women may have better long-term results than another common surgical technique, according to a study led by Mayo Clinic researchers.

15 Jul 2019

Bordeaux University Hospital uses 3D printing to improve kidney tumor removal surgery

Bordeaux University Hospital in France is leading the charge to improve success rates of complex kidney tumor removal surgery, thanks to unique full-color, multi-material 3D printing technology.

From Stratasys 15 Jul 2019

LexaGene’s beta prototype achieves 98.2% consistency with reference lab data

LexaGene Holdings, Inc., a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today the test results from its first beta prototype placed at the Massachusetts Veterinary Referral Hospital in Woburn, MA. Mass Vet is one of 24 hospitals owned and operated by Ethos Veterinary Health.

15 Jul 2019

Could hormone therapy for prostate cancer increase the risk of Alzheimer’s disease?

Men who take hormone-blocking therapy (ADT) for prostate cancer may be at an increased risk of developing dementia and Alzheimer’s disease.

8 Jul 2019

Common cold virus strain could be a breakthrough in bladder cancer treatment

Scientists in the UK have found a new way to treat bladder cancer, using a strain of one of the viruses that cause the common cold. The virus is called Coxsackie virus CVA21, and it was found to be oncolytic, or tumor-destroying.

8 Jul 2019

Adequate consumption of milk and dairy products can help prevent chronic diseases

An adequate consumption of milk and dairy products at different life stages can help prevent various chronic diseases.

3 Jul 2019

Machine learning model accurately classifies the stages of bladder cancer

The invasive and expensive diagnosis process of bladder cancer, which is one of the most common and aggressive cancers in the United States, may be soon helped by a novel non-invasive diagnostic method thanks to advances in machine learning research at the San Diego Supercomputer Center, Moores Cancer Center, and CureMatch Incorporated.

3 Jul 2019

Scientists uncover new pathway to make cancers self-destruct

For years, researchers have been trying to target a gene called MYC that is known to drive tumor growth in multiple cancer types when it is mutated or over-expressed, but hitting that target successfully has proven difficult.

1 Jul 2019

Standard tests may not detect low-level case of TB in some people

An international collaboration of infectious disease experts has identified a large group of people who appear to have naturally mounted an immune response to TB, a bacterial infection that is the leading cause of infectious disease death worldwide.

1 Jul 2019

New biomarker in urine can help detect aggressive prostate cancer

A team of researchers from UCLA and the University of Toronto have identified a new biomarker found in urine that can help detect aggressive prostate cancer, potentially saving hundreds of thousands of men each year from undergoing unnecessary surgeries and radiotherapy treatments.

1 Jul 2019

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

The U.S. Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 antibody positive.

27 Jun 2019